FdaApplication
BLA 761231
Identifiers
- fda_app_no: BLA761231
Properties
| Property | Value |
|---|---|
| applicant_name | Amneal Pharmaceuticals LLC |
| application_type | BLA |
| approval_date | 2022-04-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALYMSYS | BEVACIZUMAB-MALY | 100MG/4ML (25MG/ML) | Injection |
| ALYMSYS | BEVACIZUMAB-MALY | 400MG/16ML (25MG/ML) | Injection |
2 products